Epistasis in sporadic Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Neurobiology of Aging

• Publication date

  2009-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neurobiolaging.2007.11.027PMID 18206267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No association of dynamin binding protein (DNMBP) gene SNPs and Alzheimer's disease.

  2008cited by this paper
• Interaction between the APOE ɛ4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease

  2008cited by this paper
• Association study of cholesterol-related genes in Alzheimer’s disease

  2007cited by this paper
• Association of genetic variants of ABCA1 with Alzheimer's disease risk

  2007cited by this paper
• The cholesteryl ester transfer protein (CETP) gene and the risk of Alzheimer’s disease

  2007cited by this paper
• Genes related to iron metabolism and susceptibility to Alzheimer's disease in Basque population.

  2007cited by this paper
• Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis.

  2007cited by this paper
• Interaction between estrogen receptor-alpha and butyrylcholinesterase genes modulates Alzheimer's disease risk.

  2007cited by this paper
• Impact of the matrix metalloproteinase MMP-3 on dementia.

  2007cited by this paper
• Genetic association between polymorphisms of Pen2 gene and late onset Alzheimer's disease in the North Chinese population.

  2007cited by this paper
• The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.

  2007cited by this paper
• Interaction between estrogen receptor-α and butyrylcholinesterase genes modulates Alzheimer’s disease risk

  2007cited by this paper
• Interaction between prion protein and interleukin-1A genes increases early-onset Alzheimer’s disease risk

  2007cited by this paper
• The CDC2 I-G-T haplotype associated with the APOE ε4 allele increases the risk of sporadic Alzheimer's disease in Sicily

  2007cited by this paper
• Association of IL10 promoter polymorphism in Italian Alzheimer's disease.

  2007cited by this paper
• Detection of gene x gene interactions in genome-wide association studies of human population data.

  2007cited by this paper
• The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.

  2007cited by this paper
• Interaction between the ADAM12 and SH3MD1 genes may confer susceptibility to late‐onset Alzheimer's disease

  2007cited by this paper
• Interaction between Poly(ADP-Ribose) Polymerase 1 and Interleukin 1A Genes Is Associated with Alzheimer’s Disease Risk

  2007cited by this paper
• Genetic interaction between two apolipoprotein E receptors increases Alzheimer's disease risk

  2006cited by this paper
• Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease.

  2006cited by this paper
• Genetic variants in brain-derived neurotrophic factor associated with Alzheimer’s disease

  2006cited by this paper
• Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease.

  2006cited by this paper
• Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females.

  2006cited by this paper
• VEGF Gene and Phenotype Relation with Alzheimer's Disease and Mild Cognitive Impairment

  2006cited by this paper
• Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease.

  2006cited by this paper
• Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study.

  2006cited by this paper
• Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.

  2006cited by this paper
• Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.

  2006cited by this paper
• Case-control studies in the genomic era: a clinician's guide.

  2006cited by this paper
• Estrogen receptor α and APOEɛ4 polymorphisms interact to increase risk for sporadic AD in Italian females

  2006cited by this paper
• Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.

  2006cited by this paper
• Processing of amyloid beta-peptides by neutral cysteine protease bleomycin hydrolase.

  2006cited by this paper
• Interaction between dopamine β-hydroxylase and interleukin genes increases Alzheimer’s disease risk

  2006cited by this paper
• Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE ε4 allele

  2006cited by this paper
• Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men.

  2005cited by this paper
• Vascular endothelial growth factor gene variability is associated with increased risk for AD

  2005cited by this paper
• Cholesterol in Alzheimer's disease.

  2005cited by this paper
• Interaction between the α-T catenin gene (VR22) and APOE in Alzheimer’s disease

  2005cited by this paper
• Association studies of transforming growth factor‐β1 and Alzheimer's disease

  2005cited by this paper
• A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease.

  2005cited by this paper
• INTERLEUKIN-6 PROMOTER POLYMORPHISM AND LATE-ONSET ALZHEIMER's DISEASE IN THE FINNISH POPULATION

  2005cited by this paper
• PEN–2 gene mutation in a familial Alzheimer’s disease case

  2005cited by this paper
• Additive and multiplicative models for the joint effect of two risk factors.

  2005cited by this paper
• Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis.

  2005cited by this paper
• Glutathione S-Transferase P1 *C Allelic Variant Increases Susceptibility for Late-Onset Alzheimer Disease: Association Study and Relationship with Apolipoprotein E ε4 Allele

  2005cited by this paper
• Migraine and other headaches: Associations with Rose angina and coronary heart disease

  2005cited by this paper
• Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

  2005cited by this paper
• Association studies of transforming growth factor-beta 1 and Alzheimer's disease.

  2005cited by this paper
• Polymorphisms in the oxidized low-density lipoprotein receptor-1 gene and risk of Alzheimer's disease.

  2005cited by this paper
• Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta.

  2005cited by this paper
• CYP46: a risk factor for Alzheimer's disease or a coincidence?

  2005cited by this paper
• Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease.

  2005cited by this paper
• Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism.

  2005cited by this paper
• Genetic studies of A2M and BACE1 genes in Chinese Han Alzheimer's disease patients

  2005cited by this paper
• α1-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease

  2005cited by this paper
• An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray

  2005cited by this paper
• Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.

  2005cited by this paper
• A systems biology approach to genetic studies of complex diseases

  2005cited by this paper
• A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.

  2005cited by this paper
• Cystatin C as a risk factor for Alzheimer disease

  2005cited by this paper
• Glutathione S-transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele.

  2005cited by this paper
• Interaction between CYP19 Aromatase and Butyrylcholinesterase Genes Increases Alzheimer’s Disease Risk

  2005cited by this paper
• Functional interaction between APOE4 and LDL receptor isoforms in Alzheimer’s disease

  2005cited by this paper
• Interaction between interleukin–6 and intercellular adhesion molecule–1 genes and Alzheimer’s disease risk

  2005cited by this paper
• Insulin degrading enzyme and alpha-3 catenin polymorphisms in Italian patients with Alzheimer disease.

  2005cited by this paper
• Proinflammatory Genetic Profiles in Subjects With History of Ischemic Stroke

  2004cited by this paper
• Gene-gene interaction between interleukin-1A and interleukin-8 increases Alzheimer’s disease risk

  2004cited by this paper
• Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus

  2004cited by this paper
• Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4.

  2004cited by this paper
• [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].

  2004cited by this paper
• Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer’s disease

  2004cited by this paper
• Pathways towards and away from Alzheimer's disease

  2004cited by this paper
• Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.

  2004cited by this paper
• Assessment of association between mitochondrial aldehyde dehydrogenase polymorphism and Alzheimer's disease in an older Korean population.

  2004cited by this paper
• El polimorfismo ACT/AA podría duplicar el riesgo de enfermedad de Alzheimer asociado al alelo APOE*ε4

  2004cited by this paper
• Variants of CYP46A1 may interact with age and APOE to influence CSF Aβ42 levels in Alzheimer’s disease

  2004cited by this paper
• Clearance of Alzheimer's Aβ Peptide

  2004cited by this paper
• Neuronal expression of myeloperoxidase is increased in Alzheimer's disease

  2004cited by this paper
• SREBP-1a Polymorphism Influences the Risk of Alzheimer’s Disease in Carriers of the ApoE4 Allele

  2004cited by this paper
• Association of alpha 2-macroglobulin polymorphisms and Alzheimer disease in Mainland Han Chinese.

  2004cited by this paper
• Association between Cathepsin D Polymorphism and Alzheimer’s Disease in a Chinese Han Population

  2004cited by this paper
• Multilocus Analysis of Hypertension: A Hierarchical Approach

  2004cited by this paper
• Gene–gene interaction between interleukin-6 and interleukin-10 reduces AD risk

  2004cited by this paper
• Lipid Peroxidation and Oxidative imbalance: Early functional events in Alzheimer's disease

  2004cited by this paper
• Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese.

  2004cited by this paper
• Renin-Angiotensin System Gene Polymorphisms and Atrial Fibrillation

  2004cited by this paper
• Functional genetic polymorphisms in cytokines and metabolic genes as additional genetic markers for susceptibility to develop type 1 diabetes

  2004cited by this paper
• Epistasis, complex traits, and mapping genes

  2004cited by this paper
• No association between the insulin degrading enzyme gene and Alzheimer's disease in a Japanese population

  2004cited by this paper
• Genetic Association of CYP46 and Risk for Alzheimer’s Disease

  2004cited by this paper
• Silas Weir Mitchell and the “rest cure”

  2004cited by this paper
• Gene–gene interaction in folate-related genes and risk of neural tube defects in a UK population

  2004cited by this paper
• Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.

  2004cited by this paper
• Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review.

  2004cited by this paper
• Genetics, statistics and human disease: analytical retooling for complexity.

  2004cited by this paper
• Polymorphism in genes involved in adrenergic signaling associated with Alzheimer's.

  2004cited by this paper
• Insulin-degrading enzyme and Alzheimer disease

  2004cited by this paper
• Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.

  2004cited by this paper
• Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

  2004cited by this paper

• Turning heterogeneity of statistical epistasis networks to an advantage

  2026cites this paper
• Sign Epistasis Can be Absent in Multi-peaked Landscapes With Neutral Mutations

  2025cites this paper
• Complex genetic effects linked to plasma protein abundance in the UK Biobank

  2025cites this paper
• Synergistic Effect between the APOE ε4 Allele with Genetic Variants of GSK3B and MAPT: Differential Profile between Refractory Epilepsy and Alzheimer Disease

  2024cites this paper
• Complex genetic interactions affect susceptibility to Alzheimer's disease risk in the BIN1 and MS4A6A loci

  2024cites this paper
• Revealing third-order interactions through the integration of machine learning and entropy methods in genomic studies

  2024cites this paper
• Identification of Alzheimer’s Disease Associated Genes through Explicable Deep Learning and Bioinformatic

  2023cites this paper
• Statistical and Combinatorial Methods to Predict Gene Expression and Identify eQTLs from Haplotype Sequences

  2023cites this paper
• Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction

  2023cites this paper
• Association between H2 haplotype of microtubule associated protein tau gene (deletion / insertion) with Alzheimer Disease in Tunisian patients

  2022cites this paper
• The classification of life

  2022cites this paper
• An extension to the NK fitness landscape model to study pleiotropy, epistasis, and ruggedness independently

  2022cites this paper
• Network approaches for omics studies of neurodegenerative diseases

  2022cites this paper
• Alzheimer’s Disease Risk Variant rs3865444 in the CD33 Gene: A Possible Role in Susceptibility to Multiple Sclerosis

  2022cites this paper
• Advancing human disease research with fish evolutionary mutant models.

  2021cites this paper
• Interplay between stress-related genes may influence Alzheimer's disease development: The results of genetic interaction analyses of human data.

  2021cites this paper
• Importance-Penalized Joint Graphical Lasso (IPJGL): differential network inference via GGMs

  2021cites this paper
• Combinatorial and statistical prediction of gene expression from haplotype sequence

  2020cites this paper
• Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease.

  2020cites this paper
• Machine learning tools for biomarker discovery

  2020cites this paper
• Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer’s Disease in a Prospective Cohort Study

  2020cites this paper
• Lesch-Nyhan disease: I. Construction of expression vectors for hypoxanthine-guanine phosphoribosyltransferase (HGprt) enzyme and amyloid precursor protein (APP)

  2020cites this paper
• Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late‐onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele

  2020cites this paper
• Discovering Interacting Features for Prediction of Response submitted to Iowa State University

  2020cites this paper
• Detection of epistasis in genome wide association studies with machine learning methods for therapeutic target identification

  2020cites this paper
• The combined risk effect among BIN1, CLU, and APOE genes in Alzheimer’s disease

  2020cites this paper
• Epistasis detectably alters correlations between genomic sites in a narrow parameter window

  2019cites this paper
• An optimization approach to epistasis detection

  2019cites this paper
• Machine Learning and Computational Intelligence for High-Order Epistasis Detection

  2019cites this paper
• Modeling epistasis in mice and yeast using the proportion of two or more distinct genetic backgrounds: Evidence for “polygenic epistasis”

  2019cites this paper
• Deep mixed model for marginal epistasis detection and population stratification correction in genome-wide association studies

  2019cites this paper
• β-Amyloid precursor protein (APP) and the human diseases

  2019cites this paper
• EPISTASIS IN ALZHEIMER ’ S DISEASE : INTERACTIONS BETWEEN CLU-MS 4 A 4 E AND WWC 1-TLN 2

  2019cites this paper
• Gestión de volúmenes masivos de datos genéticos y análisis de la influencia de su interacción en el desarrollo de cáncer

  2019cites this paper
• Transmission Genetics: An Integrative Approach. Alzheimer's Dementia

  2019cites this paper
• Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer’s disease in large cohort

  2019cites this paper
• Evolution, From the Beginning

  2019cites this paper
• A multiplex analysis of sepsis mediators during human septic shock: a preliminary study on myocardial depression and organ failures

  2019cites this paper
• New algorithms for detecting multi-effect and multi-way epistatic interactions

  2019cites this paper
• The Effects of Mutations are Modified by Genetic Background in Mice

  2019cites this paper
• Novel methods for epistasis detection in genome-wide association studies

  2018cites this paper
• Special Issue: Alzheimer's disease

  2018cites this paper
• MatrixEpistasis: ultrafast, exhaustive epistasis scan for quantitative traits with covariate adjustment

  2018cites this paper
• Evolutionary footprint of epistasis

  2018cites this paper
• Introduction: Seriously, What is Precision Medicine?

  2018cites this paper
• Alzheimer's disease susceptibility genes modify the risk of Parkinson disease and Parkinson's disease-associated cognitive impairment.

  2018cites this paper
• An assessment of true and false positive detection rates of stepwise epistatic model selection as a function of sample size and number of markers

  2018cites this paper
• Epistatic interaction of apolipoprotein E and lipolysis-stimulated lipoprotein receptor genetic variants is associated with Alzheimer's disease.

  2018cites this paper
• Pro-neurogenic, Memory-Enhancing and Anti-stress Effects of DF302, a Novel Fluorine Gamma-Carboline Derivative with Multi-target Mechanism of Action

  2017cites this paper
• APOE and MS4A6A interact with GnRH signaling in Alzheimer's disease: Enrichment of epistatic effects

  2017cites this paper
• Toward a Network-Based Approach to Modeling Epistatic Interactions in Genome-Wide Association Studies

  2017cites this paper
• Predicting Cognitive Decline: Genetic, Environmental and Lifestyle Risk Factors

  2017influential citation
• Environmental and genetic modifiers of Shudderer, a Drosophila voltage-gated sodium channel mutant

  2016cites this paper
• A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer's Disease

  2016cites this paper
• Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy

  2016cites this paper
• Presenilin E318G variant and Alzheimer’s disease risk: the Cache County study

  2016cites this paper
• NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS

  2016cites this paper
• Pathway Analysis Incorporating Protein-Protein Interaction Networks Identified Candidate Pathways for the Seven Common Diseases

  2016cites this paper
• Time-Dependent Gene Network Modelling by Sequential Monte Carlo

  2016cites this paper
• Genetic variants in Alzheimer disease — molecular and brain network approaches

  2016cites this paper
• Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment

  2016cites this paper
• Phenotypic characterization of a pair of molecules in tissues confer to classical Mendelian or non Mendelian ratios.

  2016cites this paper
• Dynamics of gene expression in the genotype-phenotype map

  2016cites this paper
• Functional and evolutionary implications of in silico gene deletions

  2016cites this paper
• Featured Article Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk

  2016cites this paper
• Mutation in the Human HPRT1 Gene and the Lesch-Nyhan Syndrome

  2016cites this paper
• Identifying Highly Penetrant Disease Causal Mutations Using Next Generation Sequencing: Guide to Whole Process

  2015cites this paper
• Genetics of Vascular Dementia: Systematic Review and Meta-Analysis

  2015cites this paper
• Epigenetic Regulation in Amyloid Precursor Protein with Genomic Rearrangements and the Lesch-Nyhan Syndrome

  2015cites this paper
• Confronting the missing epistasis problem: on the reproducibility of gene–gene interactions

  2015cites this paper
• Defining the Genetic Architecture of Alzheimer's Disease: Where Next?

  2015cites this paper
• Epistasis in the risk of human neuropsychiatric disease.

  2015cites this paper
• The human β-amyloid precursor protein: biomolecular and epigenetic aspects

  2015cites this paper
• The Context-Dependence of Mutations: A Linkage of Formalisms

  2015cites this paper
• Interaction between variants in CLU and MS4A4E modulates Alzheimer’s disease risk

  2015cites this paper
• Additional mechanisms conferring genetic susceptibility to Alzheimer’s disease

  2015influential citation
• Bridging the Gap between Statistical and Biological Epistasis in Alzheimer's Disease

  2015cites this paper
• Association between the CETP polymorphisms and the risk of Alzheimer's disease, carotid atherosclerosis, longevity, and the efficacy of statin therapy.

  2014cites this paper
• Synergistic Epistasis of Paraoxonase 1 (rs662 and rs85460) and Apolipoprotein E4 Genes in Pathogenesis of Alzheimer’s Disease and Vascular Dementia

  2014cites this paper
• Population-based analysis of Alzheimer's disease risk alleles implicates genetic interactions.

  2014cites this paper
• Identifying highly-penetrant disease causal mutations using next generation sequencing: Guide to whole process

  2014cites this paper
• Detecting epistasis in human complex traits

  2014cites this paper
• Molecular network analysis enhances understanding of the biology of mental disorders

  2014cites this paper
• Kernel machine methods for analysis of genomic data from different sources

  2014cites this paper
• Exploitation of complex network topology for link prediction in biological interactomes

  2014cites this paper
• Cuckoo search epistasis: a new method for exploring significant genetic interactions

  2014influential citation
• Role of Epistasis in Alzheimer's Disease Genetics

  2014cites this paper
• Genetic Risk Factors for Alzheimer’s Disease

  2014cites this paper
• Dementia: Genes, Environments, Interactions

  2014cites this paper
• Informative Bayesian Model Selection: a method for identifying interactions in genome-wide data.

  2014cites this paper
• Epigenetic regulation in amyloid precursor protein and the Lesch-Nyhan syndrome.

  2014cites this paper
• Alzheimer’s Disease: Analyzing the Missing Heritability

  2013cites this paper
• Mitochondrial Genetics of Alzheimer's Disease and Aging

  2013cites this paper
• Genetics of Alzheimer's Disease

  2013cites this paper
• Exploitation of genetic interaction network topology for the prediction of epistatic behavior.

  2013cites this paper
• Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease.

  2013cites this paper
• Detecting epistasis in the presence of linkage disequilibrium: A focused comparison

  2013cites this paper
• [Genetics and Alzheimer's disease: a population at risk].

  2013cites this paper
• Lessons from genome‐wide association studies findings in Alzheimer's disease

  2012cites this paper
• Organization principles in genetic interaction networks.

  2012cites this paper